MOLINA HEALTHCARE INC (MOH) Fundamental Analysis & Valuation

NYSE:MOH • US60855R1005

144.47 USD
-3.24 (-2.19%)
At close: Mar 6, 2026
143.78 USD
-0.69 (-0.48%)
After Hours: 3/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MOH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MOH. MOH was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of MOH get a neutral evaluation. Nothing too spectacular is happening here. MOH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. MOH Profitability Analysis

1.1 Basic Checks

  • In the past year MOH was profitable.
  • MOH had a negative operating cash flow in the past year.
  • In the past 5 years MOH has always been profitable.
  • Of the past 5 years MOH 4 years had a positive operating cash flow.
MOH Yearly Net Income VS EBIT VS OCF VS FCFMOH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • With a decent Return On Assets value of 3.03%, MOH is doing good in the industry, outperforming 64.36% of the companies in the same industry.
  • MOH's Return On Equity of 11.60% is fine compared to the rest of the industry. MOH outperforms 77.23% of its industry peers.
  • The Return On Invested Capital of MOH (7.39%) is better than 68.32% of its industry peers.
  • MOH had an Average Return On Invested Capital over the past 3 years of 14.32%. This is significantly above the industry average of 9.04%.
  • The 3 year average ROIC (14.32%) for MOH is well above the current ROIC(7.39%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.03%
ROE 11.6%
ROIC 7.39%
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
MOH Yearly ROA, ROE, ROICMOH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • With a Profit Margin value of 1.04%, MOH perfoms like the industry average, outperforming 57.43% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MOH has declined.
  • MOH has a Operating Margin of 1.73%. This is comparable to the rest of the industry: MOH outperforms 48.51% of its industry peers.
  • In the last couple of years the Operating Margin of MOH has declined.
  • MOH has a worse Gross Margin (13.07%) than 67.33% of its industry peers.
  • In the last couple of years the Gross Margin of MOH has declined.
Industry RankSector Rank
OM 1.73%
PM (TTM) 1.04%
GM 13.07%
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
MOH Yearly Profit, Operating, Gross MarginsMOH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MOH Health Analysis

2.1 Basic Checks

  • MOH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, MOH has less shares outstanding
  • Compared to 5 years ago, MOH has less shares outstanding
  • MOH has a worse debt/assets ratio than last year.
MOH Yearly Shares OutstandingMOH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MOH Yearly Total Debt VS Total AssetsMOH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • MOH has an Altman-Z score of 4.19. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
  • MOH's Altman-Z score of 4.19 is fine compared to the rest of the industry. MOH outperforms 77.23% of its industry peers.
  • MOH has a Debt/Equity ratio of 0.97. This is a neutral value indicating MOH is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.97, MOH perfoms like the industry average, outperforming 41.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 4.19
ROIC/WACC0.93
WACC7.93%
MOH Yearly LT Debt VS Equity VS FCFMOH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • MOH has a Current Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
  • MOH has a Current ratio of 1.69. This is in the better half of the industry: MOH outperforms 68.32% of its industry peers.
  • A Quick Ratio of 1.69 indicates that MOH should not have too much problems paying its short term obligations.
  • MOH has a Quick ratio of 1.69. This is in the better half of the industry: MOH outperforms 70.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
MOH Yearly Current Assets VS Current LiabilitesMOH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. MOH Growth Analysis

3.1 Past

  • The earnings per share for MOH have decreased strongly by -52.98% in the last year.
  • The Earnings Per Share has been decreasing by -0.02% on average over the past years.
  • The Revenue has grown by 11.75% in the past year. This is quite good.
  • Measured over the past years, MOH shows a quite strong growth in Revenue. The Revenue has been growing by 18.52% on average per year.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%

3.2 Future

  • MOH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.69% yearly.
  • Based on estimates for the next years, MOH will show a small growth in Revenue. The Revenue will grow by 4.17% on average per year.
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MOH Yearly Revenue VS EstimatesMOH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
MOH Yearly EPS VS EstimatesMOH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

3

4. MOH Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.57, MOH is valued correctly.
  • 86.14% of the companies in the same industry are more expensive than MOH, based on the Price/Earnings ratio.
  • MOH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.29.
  • Based on the Price/Forward Earnings ratio of 18.58, the valuation of MOH can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, MOH is valued a bit cheaper than the industry average as 62.38% of the companies are valued more expensively.
  • MOH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.57
Fwd PE 18.58
MOH Price Earnings VS Forward Price EarningsMOH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.89
MOH Per share dataMOH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MOH's earnings are expected to grow with 13.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.58%
EPS Next 3Y13.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MOH Dividend Analysis

5.1 Amount

  • No dividends for MOH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MOH Fundamentals: All Metrics, Ratios and Statistics

MOLINA HEALTHCARE INC

NYSE:MOH (3/6/2026, 8:04:00 PM)

After market: 143.78 -0.69 (-0.48%)

144.47

-3.24 (-2.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05
Earnings (Next)04-22
Inst Owners105.33%
Inst Owner Change-7.91%
Ins Owners1.33%
Ins Owner Change10.61%
Market Cap7.44B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts65
Price Target156.67 (8.44%)
Short Float %7.49%
Short Ratio2.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-12.12%
PT rev (3m)-10.16%
EPS NQ rev (1m)-38.73%
EPS NQ rev (3m)-35.09%
EPS NY rev (1m)-44.06%
EPS NY rev (3m)-42.68%
Revenue NQ rev (1m)-5.1%
Revenue NQ rev (3m)-5.23%
Revenue NY rev (1m)-4%
Revenue NY rev (3m)-4.35%
Valuation
Industry RankSector Rank
PE 13.57
Fwd PE 18.58
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 1.83
P/tB 3.97
EV/EBITDA -0.89
EPS(TTM)10.65
EY7.37%
EPS(NY)7.78
Fwd EY5.38%
FCF(TTM)-12.35
FCFYN/A
OCF(TTM)-10.39
OCFYN/A
SpS882.06
BVpS79.01
TBVpS36.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number137.6
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 11.6%
ROCE 9.57%
ROIC 7.39%
ROICexc N/A
ROICexgc N/A
OM 1.73%
PM (TTM) 1.04%
GM 13.07%
FCFM N/A
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 51.79%
Cap/Sales 0.22%
Interest Coverage 4.33
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z 4.19
F-Score4
WACC7.93%
ROIC/WACC0.93
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-29.1%
EBIT Next 3Y6.7%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A

MOLINA HEALTHCARE INC / MOH FAQ

Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?

ChartMill assigns a fundamental rating of 5 / 10 to MOH.


What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?

ChartMill assigns a valuation rating of 6 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.


How profitable is MOLINA HEALTHCARE INC (MOH) stock?

MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for MOH stock?

The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 13.57 and the Price/Book (PB) ratio is 1.83.